Published in World J Surg on December 11, 2001
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88
Efficacy of loco-regional ablation therapy of HCC in a population of liver transplanted patients. Dig Dis Sci (2007) 1.41
Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol (2004) 0.98
131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors. World J Surg (2004) 0.92
Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series. World J Surg (2010) 0.84
Tumor response to transcatheter arterial chemoembolization in recurrent hepatocellular carcinoma after living donor liver transplantation. Korean J Radiol (2007) 0.83
Management of "very early" hepatocellular carcinoma on cirrhotic patients. World J Hepatol (2014) 0.82
Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study. Clin Transplant (2010) 0.81
Measurement of intrahepatic pressure during radiofrequency ablation in porcine liver. J Gastroenterol (2009) 0.80
Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma. HPB (Oxford) (2008) 0.78
Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening. BMC Gastroenterol (2015) 0.78
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol (2017) 0.78
Multidisciplinary management of recurrent hepatocellular carcinoma following liver transplantation. J Gastrointest Surg (2012) 0.77
Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity. World J Gastroenterol (2004) 0.77
Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World J Gastroenterol (2016) 0.76
Liver transplantation for hepatocellular carcinoma: a single European centre experience. Langenbecks Arch Surg (2004) 0.75
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol (2006) 5.17
Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl (2005) 2.04
The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res (2009) 1.87
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area. Liver Transpl (2009) 1.43
[One thousand liver transplants. Hospital Clinic i Provincial de Barcelona (Spain)]. Cir Esp (2005) 1.39
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg (2005) 1.01
Predictive factors for early mortality following liver transplantation. Clin Transplant (2003) 1.01
Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation (2008) 0.96
Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer. Ann Surg Oncol (2008) 0.95
A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells. Clin Cancer Res (2013) 0.94
Liver transplantation in HIV-HCV coinfected patients: a case-control study. Transplantation (2007) 0.91
Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers. J Hepatol (2004) 0.91
Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol (2005) 0.90
Successful transplantation of organs from a donor with postneurosurgical meningitis caused by Escherichia coli. Transplantation (2012) 0.90
A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C. Transpl Int (2005) 0.89
Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content. Obes Surg (2008) 0.89
Hemodynamic consequences of spontaneous splenorenal shunts in deceased donor liver transplantation. Liver Transpl (2011) 0.88
Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol (2012) 0.88
Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis. Obes Surg (2009) 0.88
Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma. J Hepatobiliary Pancreat Sci (2011) 0.87
Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86
Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series. World J Surg (2010) 0.84
Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. World J Hepatol (2012) 0.84
A cost effective analysis of a laparoscopic versus an open left lateral sectionectomy in a liver transplant unit. HPB (Oxford) (2014) 0.83
Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation. Liver Transpl (2002) 0.83
Fine needle aspiration cytology of massive bilateral ovarian metastasis of fibrolamellar hepatocellular carcinoma. Acta Cytol (2007) 0.82
FK506 in the maturation of dendritic cells. Haematologica (2002) 0.82
Meta-analysis of Duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis. Transpl Int (2015) 0.81
Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antivir Ther (2006) 0.81
Liver transplantation in hepatocellular carcinoma. Transpl Int (2005) 0.81
Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature. Liver Transpl (2012) 0.81
Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation. Liver Int (2012) 0.80
Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure. Liver Int (2013) 0.79
Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study. Clin Transplant (2011) 0.79
Visceral leishmaniasis among liver transplant recipients: an overview. Liver Transpl (2008) 0.79
Liver biopsy-related infection in liver transplant recipients: A current matter of concern? Liver Transpl (2014) 0.78
Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis. World J Gastroenterol (2009) 0.78
Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation. Liver Transpl (2011) 0.77
Optimization of liver grafts in liver retransplantation: a European single-center experience. Surgery (2008) 0.77
Impact of prior portosystemic shunt procedures on outcome of liver transplantation. Surgery (2005) 0.77
Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients. Transplantation (2012) 0.76
[Krukenberg's tumor as the first clinical manifestation of fibrolamellar hepatocarcinoma]. Gastroenterol Hepatol (2008) 0.76
[Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery]. Cir Esp (2006) 0.76
Severe preprocurement blunt trauma to the liver: is there a need for back-table cutdown? Liver Transpl (2009) 0.75
Imaging of hepatitis C virus infection in liver grafts after liver transplantation. J Hepatol (2013) 0.75
Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues? Ann Hepatol (2011) 0.75
Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients. Liver Transpl (2011) 0.75
[Therapeutic management of juxtapapillary duodenal diverticulum]. Cir Esp (2012) 0.75
Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantation. Transpl Int (2003) 0.75
[Biliary adenocarcinoma arising from atypical benign lesions]. Cir Esp (2005) 0.75
Xanthine oxidoreductase and preservation injury in human liver transplantation. Transplantation (2004) 0.75
Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study. Liver Transpl (2014) 0.75
Low plasma levels of antithrombin III in the early post-operative period following pediatric liver transplantation: should they be replaced? A single-center pilot study. Pediatr Transplant (2014) 0.75
Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis. Pancreas (2017) 0.75